CALL - SPRINTER OPEN END - DEXCOM Stock

DE000VM553V4

Delayed Deutsche Boerse AG 10:44:28 2024-05-27 am EDT
1.24 ^EUR	-8.82%

Current month	-8.11%
1 month	-41.38%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes	May. 20	BU
DexCom : Human Rights Statement	May. 08	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	Apr. 30	CI
Wall Street: the worst week of 2024 is followed by the best	Apr. 26	CF

More news

Quotes 5-day view

Date	Price	Change
24-05-27	1.24	-8.82%
24-05-24	1.36	+1.49%
24-05-23	1.34	-19.28%
24-05-22	1.66	-1.78%
24-05-21	1.69	-0.59%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 10:44 am EDT

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Vontobel
WKN	VM553V
ISIN	DE000VM553V4
Date issued	2023-11-29
Strike	113.2 $
Maturity	Unlimited
Parity	10 : 1
Emission price	0.38 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.85 €
Lowest since issue	0.26 €

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

127.4 USD

Average target price

151.2 USD

Spread / Average Target

+18.73%

Consensus